| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $87,793 ) |
| | 2026 | 2026 | THE GOVERNORS OF THE UNIVERSITY OF CALGARY | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS109481 | Multiple sclerosis as a cytodegenerative proteopathy | 000 | 5 | NIH | 6/19/2026 | $87,793 |
| | 2026 | 2025 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS121016 | Redefining the zoonotic potential of chronic wasting disease | 000 | 5 | NIH | 4/15/2026 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $2,012,416 ) |
| | 2025 | 2025 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS121016 | Redefining the zoonotic potential of chronic wasting disease | 000 | 5 | NIH | 4/25/2025 | $270,000 |
| | 2025 | 2025 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI165327 | Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | 000 | 5 | NIH | 9/3/2025 | $1,459,892 |
| | 2025 | 2025 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS109481 | Multiple sclerosis as a cytodegenerative proteopathy | 001 | 4 | NIH | 8/7/2025 | $28,779 |
| | 2025 | 2025 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS109481 | Multiple sclerosis as a cytodegenerative proteopathy | 000 | 4 | NIH | 1/1/2025 | $259,014 |
| | 2025 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI141229 | Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance | 000 | 5 | NIH | 4/29/2025 | -$5,269 |
|
| Issue Date FY: 2024 ( Subtotal = $3,756,863 ) |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01OD016575 | Transplantation of Testis Stem Cells in Large Animals | 000 | 21 | NIH | 1/31/2024 | $191,246 |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI165327 | Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | 000 | 4 | NIH | 8/16/2024 | $1,959,301 |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS121016 | Redefining the zoonotic potential of chronic wasting disease | 000 | 4 | NIH | 5/17/2024 | $261,900 |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01OD016575 | Transplantation of Testis Stem Cells in Large Animals | 001 | 21 | NIH | 5/17/2024 | $47,812 |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI141229 | Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance | 001 | 5 | NIH | 4/19/2024 | $101,753 |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI141229 | Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance | 000 | 5 | NIH | 12/19/2023 | $915,765 |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS109481 | Multiple sclerosis as a cytodegenerative proteopathy | 001 | 3 | NIH | 4/10/2024 | $20,145 |
| | 2024 | 2024 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS109481 | Multiple sclerosis as a cytodegenerative proteopathy | 000 | 3 | NIH | 1/2/2024 | $259,014 |
| | 2024 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R21AI151680 | Defining a role for monocyte licensing in the regulation of Leishmania-specific T cell immunity following short- and long-term pre-exposure to sand fly blood feeding | 000 | 2 | NIH | 7/19/2024 | -$73 |
|
| Issue Date FY: 2023 ( Subtotal = $3,438,475 ) |
| | 2023 | 2023 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01OD016575 | Transplantation of Testis Stem Cells in Large Animals | 000 | 20 | NIH | 2/18/2023 | $239,058 |
| | 2023 | 2023 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI165327 | Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | 000 | 3 | NIH | 8/24/2023 | $1,468,940 |
| | 2023 | 2023 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS121016 | Redefining the zoonotic potential of chronic wasting disease | 001 | 3 | NIH | 5/5/2023 | $270,000 |
| | 2023 | 2023 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI165327 | Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | 001 | 3 | NIH | 9/22/2023 | $570,215 |
| | 2023 | 2023 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI141229 | Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance | 000 | 4 | NIH | 12/23/2022 | $602,472 |
| | 2023 | 2023 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS109481 | Multiple sclerosis as a cytodegenerative proteopathy | 000 | 2 | NIH | 2/20/2023 | $287,793 |
| | 2023 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS121016 | Redefining the zoonotic potential of chronic wasting disease | 000 | 2 | NIH | 4/13/2023 | $0 |
| | 2023 | 2020 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R03HD097548 | An animal model for identifying regulatory sequences of the human SHOX gene | 000 | 2 | NIH | 7/27/2023 | $0 |
| | 2023 | 2019 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R34AI136783 | Volume Expansion in Children with Shiga Toxin-Producing E. coli Infection to Prevent or Mitigate Hemolytic Uremic Syndrome: Planning a Multinational Randomized Clinical Trial | 000 | 1 | NIH | 11/23/2022 | $0 |
| | 2023 | 2019 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01HD091068 | iPSC-derived Organoids to Study Testis Function | 000 | 3 | NIH | 11/14/2022 | -$3 |
|
| Issue Date FY: 2022 ( Subtotal = $2,314,730 ) |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R21AI151680 | Defining a role for monocyte licensing in the regulation of Leishmania-specific T cell immunity following short- and long-term pre-exposure to sand fly blood feeding | 000 | 2 | NIH | 12/2/2021 | $147,992 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI165327 | Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | 001 | 2 | NIH | 8/25/2022 | $1,472,834 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS121016 | Redefining the zoonotic potential of chronic wasting disease | 000 | 2 | NIH | 4/18/2022 | $270,000 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01OD016575 | Transplantation of Testis Stem Cells in Large Animals | 001 | 19 | NIH | 5/17/2022 | $23,905 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01OD016575 | Transplantation of Testis Stem Cells in Large Animals | 000 | 19 | NIH | 2/9/2022 | $215,153 |
| | 2022 | 2022 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS109481 | Multiple sclerosis as a cytodegenerative proteopathy | 000 | 1 | NIH | 1/31/2022 | $287,793 |
| | 2022 | 2021 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI141229 | Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance | 000 | 3 | NIH | 2/17/2022 | $0 |
| | 2022 | 2021 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI165327 | Hyperhydration to Improve Kidney Outcomes in Children with Shiga Toxin-Producing E. Coli Infection (HIKO STEC): A Multinational, Embedded, Cluster, Crossover, Randomized Trial | 000 | 1 | NIH | 12/8/2021 | $0 |
| | 2022 | 2019 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01MH085300 | 3/3 Brain Function and Genetics in Pediatric Obsessive-Compulsive Behaviors | 002 | 10 | NIH | 3/8/2022 | -$90,930 |
| | 2022 | 2019 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01MH085300 | 3/3 Brain Function and Genetics in Pediatric Obsessive-Compulsive Behaviors | 001 | 10 | NIH | 2/28/2022 | $177,282 |
| | 2022 | 2019 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01MH085300 | 3/3 Brain Function and Genetics in Pediatric Obsessive-Compulsive Behaviors | 000 | 10 | NIH | 10/27/2021 | -$177,282 |
| | 2022 | 2019 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R34AI136783 | Volume Expansion in Children with Shiga Toxin-Producing E. coli Infection to Prevent or Mitigate Hemolytic Uremic Syndrome: Planning a Multinational Randomized Clinical Trial | 000 | 1 | NIH | 4/22/2022 | -$10,563 |
| | 2022 | 2018 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | U01MH081984 | "7/9" Predictors and Mechanisms of Conversion to Psychosis | 001 | 10 | NIH | 8/25/2022 | $20 |
| | 2022 | 2018 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | U01MH081984 | "7/9" Predictors and Mechanisms of Conversion to Psychosis | 000 | 10 | NIH | 8/8/2022 | -$1,475 |
|
| Issue Date FY: 2021 ( Subtotal = $2,983,819 ) (Continued on the next page) |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R21AI151680 | Defining a role for monocyte licensing in the regulation of Leishmania-specific T cell immunity following short- and long-term pre-exposure to sand fly blood feeding | 000 | 1 | NIH | 11/26/2020 | $147,992 |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01NS121016 | Redefining the zoonotic potential of chronic wasting disease | 000 | 1 | NIH | 5/31/2021 | $270,000 |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01OD016575 | Transplantation of Testis Stem Cells in Large Animals | 000 | 18 | NIH | 2/23/2021 | $239,058 |
| | 2021 | 2021 | GOVERNORS OF THE UNIVERSITY OF CALGARY, THE | 2500 UNIVERSITY DR NW | CALGARY | AB | | | CAN | R01AI141229 | Production of a Gonococcal Vaccine for Countering Antimicrobial Resistance | 000 | 3 | NIH | 1/27/2021 | $810,000 |
|
